Search - tctmd.com

Displaying 561 - 580 of 1027

Sort: Relevancy | Date

News Daily News

SPIRIT Meta-analysis Confirms Overall Superiority of Xience over Taxus

September 20, 2013

News Daily News

Baroreflex Sensitivity May Help Target Likely Responders to Renal Denervation

September 13, 2013

News Industry News

Boston Scientific Concludes Enrollment In Randomized, Multicenter, Pivotal Study Of SYNERGY™ Coronary Stent System

September 12, 2013

News Conference News ESC 2013

BIC-8: Positive Signs for Early-Rule Out of Suspected ACS Using Copeptin

Caitlin E. Cox

September 03, 2013

News Conference News ESC 2013

Length of DAPT, Reasons for Discontinuation Have Disparate Effects

Yael L. Maxwell

September 01, 2013

News Daily News

Una Serie de Casos Muestra la Curva de Aprendizaje de las Controvertidas Angioplastias en el Tratamiento de la EM

L.A. McKeown

August 30, 2013

News Daily News

Case Series Shows Learning Curve of Controversial MS Angioplasty Procedure

L.A. McKeown

August 30, 2013

News Industry News

Boston Scientific Completes Enrollment In SuperNOVA Trial Evaluating Innova™ Self-Expanding Stent System

August 19, 2013

News Daily News

Contemporary ZES Perform Well in Treating In-Stent Restenosis

August 14, 2013

News Daily News

Patency Higher, Reintervention Lower with Stenting vs. Surgery in PAD

August 12, 2013

News Daily News

No Increased Mortality Risk for DES Patients with High Platelet Reactivity on Clopidogrel

L.A. McKeown

August 12, 2013

News Daily News

No hay un Mayor Riesgo de Mortalidad para Pacientes SLF con Reactividad Alta al Clopidogrel

L.A. McKeown

August 12, 2013

News Daily News

Un Dispositivo Recuperador de Stents Resulta Prometedor contra los ACV Isquémicos Agudos

L.A. McKeown

August 08, 2013

News Daily News

Stent Retriever Device Shows Promise in Acute Ischemic Stroke

L.A. McKeown

August 08, 2013

News Daily News

Add-on Cilostazol Reduces Restenosis in High-Risk Patients Receiving DES

August 08, 2013

News Industry News

First Patients Enrolled in REMEDEE Registry to Evaluate Long-Term Safety and Performance of OrbusNeich’s COMBO Dual Therapy Stent™ in Routine Practice

August 06, 2013

News Daily News

Apixaban Benefits A-fib Patients Regardless of Previous Warfarin Use

Jason Kahn

August 06, 2013

News Daily News

Novel Urinary Inflammation Marker Sharpens Prognosis of Stable CAD

August 05, 2013

News Daily News

For Inoperable Patients, TAVR Carries Benefits but Raises Lifetime Costs

July 25, 2013

News Daily News

Renal Denervation Safe, Effective for Moderate Resistant Hypertension in Pilot Study

July 19, 2013

Advertisement

SPIRIT Meta-analysis Confirms Overall Superiority of Xience over Taxus

Baroreflex Sensitivity May Help Target Likely Responders to Renal Denervation

Boston Scientific Concludes Enrollment In Randomized, Multicenter, Pivotal Study Of SYNERGY™ Coronary Stent System

BIC-8: Positive Signs for Early-Rule Out of Suspected ACS Using Copeptin

Length of DAPT, Reasons for Discontinuation Have Disparate Effects

Una Serie de Casos Muestra la Curva de Aprendizaje de las Controvertidas Angioplastias en el Tratamiento de la EM

Case Series Shows Learning Curve of Controversial MS Angioplasty Procedure

Boston Scientific Completes Enrollment In SuperNOVA Trial Evaluating Innova™ Self-Expanding Stent System

Contemporary ZES Perform Well in Treating In-Stent Restenosis

Patency Higher, Reintervention Lower with Stenting vs. Surgery in PAD

No Increased Mortality Risk for DES Patients with High Platelet Reactivity on Clopidogrel

No hay un Mayor Riesgo de Mortalidad para Pacientes SLF con Reactividad Alta al Clopidogrel

Un Dispositivo Recuperador de Stents Resulta Prometedor contra los ACV Isquémicos Agudos

Stent Retriever Device Shows Promise in Acute Ischemic Stroke

Add-on Cilostazol Reduces Restenosis in High-Risk Patients Receiving DES

First Patients Enrolled in REMEDEE Registry to Evaluate Long-Term Safety and Performance of OrbusNeich’s COMBO Dual Therapy Stent™ in Routine Practice

Apixaban Benefits A-fib Patients Regardless of Previous Warfarin Use

Novel Urinary Inflammation Marker Sharpens Prognosis of Stable CAD

For Inoperable Patients, TAVR Carries Benefits but Raises Lifetime Costs

Renal Denervation Safe, Effective for Moderate Resistant Hypertension in Pilot Study

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content